Publications

Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.

WATSON-JONES, D;

2022

(2022).

Advancing Mathematical Models of Mycobacterium tuberculosis Transmission to Support Vaccine Introduction.

WEERASURIYA, CK;

2022

(2022). 10.17037/PUBS.04665244.

The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis.

NATUKUNDA, A; ZIRIMENYA, L; Nassuuna, J; NKURUNUNGI, G; COSE, S; ELLIOTT, AM; WEBB, EL;

2022

Parasite Immunology, (2022).44 9 10.1111/pim.12939.

The seroprevalence, waning rate, and protective duration of anti-diphtheria toxoid IgG antibody in Nha Trang, Vietnam.

KITAMURA, N; Le, LT; Le, TT T; Nguyen, H-AT; EDWARDS, T; Madaniyazi, L; Bui, MX; Do, HT; Dang, D-A; Toizumi, M; FINE, P; Yoshida, L-M;

2022

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2022).116, 10.1016/j.ijid.2022.01.025.

Vaccine Equity in Low and Middle Income Countries: A Systematic Review and Meta-analysis.

Ali, H; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; Vynnycky, E; Woodruff, K; Ferguson, N; Toor, J; Gaythorpe, KA M;

2022

medRxiv (2022). 10.1101/2022.03.23.22272812.

Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.

Sharan, A; Stuurman, AL; Jahagirdar, S; Elango, V; Riera-Montes, M; Kashyap, NK; Biccler, J; Poluru, R; Arora, NK; Mathai, M; MANGTANI, P; Devlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Moran, A; Maure, CG; WHO Global Vaccine Safety Multi-Country Collaborat,;

2022

EClinicalMedicine, (2022).50, 10.1016/j.eclinm.2022.101506.

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study.

MACKENZIE, GA; OSEI, I; Salaudeen, R; Secka, O; D'ALESSANDRO, U; CLARKE, E; Schmidt-Chanasit, J; Licciardi, PV; Nguyen, C; GREENWOOD, B; Mulholland, K;

2022

TRIALS, (2022).23 1 10.1186/s13063-021-05949-4.

Add-Vacc trial.

WATSON-JONES, D;

2022

(2022).

Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014-2015.

Chan, Y; Martin, D; Mace, KE; Jean, SE; STRESMAN, G; DRAKELEY, C; Chang, MA; Lemoine, JF; Udhayakumar, V; Lammie, PJ; Priest, JW; Rogier, EW;

2022

Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.897013.

Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.

Skirrow, H; Barnett, S; BELL, S; Riaposova, L; MOUNIER-JACK, S; KAMPMANN, B; Holder, B;

2022

BMC pregnancy and childbirth, (2022).22 1 10.1186/s12884-021-04321-3.